SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $54,000 | +58.8% | 3,604 | +27.6% | 0.00% | – |
| Q1 2016 | $34,000 | 0.0% | 2,824 | +30.8% | 0.00% | – |
| Q4 2015 | $34,000 | -19.0% | 2,159 | -21.5% | 0.00% | – |
| Q3 2015 | $42,000 | +110.0% | 2,751 | +239.6% | 0.00% | – |
| Q2 2015 | $20,000 | +33.3% | 810 | +28.8% | 0.00% | – |
| Q1 2015 | $15,000 | -6.2% | 629 | -0.5% | 0.00% | – |
| Q4 2014 | $16,000 | -30.4% | 632 | -13.7% | 0.00% | – |
| Q3 2014 | $23,000 | +15.0% | 732 | -3.6% | 0.00% | – |
| Q2 2014 | $20,000 | +66.7% | 759 | +42.1% | 0.00% | – |
| Q1 2014 | $12,000 | -14.3% | 534 | +0.2% | 0.00% | – |
| Q4 2013 | $14,000 | -46.2% | 533 | -57.6% | 0.00% | – |
| Q3 2013 | $26,000 | +85.7% | 1,257 | +87.6% | 0.00% | – |
| Q2 2013 | $14,000 | – | 670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |